As of May 22
| +0.08 / +0.30%|
The 9 analysts offering 12-month price forecasts for Insmed Inc have a median target of 37.00, with a high estimate of 56.00 and a low estimate of 29.00. The median estimate represents a +40.10% increase from the last price of 26.41.
The current consensus among 9 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.